FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Draeger Anesthesia Workstation Correction Expanded

Draeger expands a 10/2024 device correction (Class 1 recall) to include additional Atlan A350 and A350XL anesthesia workstations used in operating roo...

latest-news-card-1
Human Drugs

FDA Warns Pharmathen Over Sterility, Data Integrity Concerns

FDA sends a Warning Letter to Greek contract manufacturer Pharmathen International citing significant GMP violations at its sterile drug manufacturing...

latest-news-card-1
Biologics

Panel to Weigh Favorable Data on Moderna's mRNA Flu Vaccine

A 6/18 advisory committee meeting is set to review Moderna's investigational mRNA influenza vaccine as the agency posts a briefing document revealing ...

latest-news-card-1
Human Drugs

FDA Delays Isotretinoin REMS Modifications

FDA says there is an implementation delay for isotretinoin iPLEDGE Risk Evaluation and Mitigation Strategy modifications.

latest-news-card-1
Medical Devices

Zoll Medical QSR, MDR Violations

FDA warns Chelmsford, ME-based Zoll Medical about Quality System and Medical Device Reporting violations in its manufacturing of several medical devic...

latest-news-card-1
Human Drugs

Petition urges FDA to Ban Gadolinium MRI Contrast Agents

A citizen petition urges FDA to impose an immediate moratorium on the use of gadolinium-based contrast agents in MRI scans.

latest-news-card-1
Human Drugs

FDA Authorizes Colorado Prescription Drug Importation Program

FDA authorizes Colorado's prescription drug importation program, marking another step forward for state-led efforts to lower drug costs through import...

latest-news-card-1
FDA General

FDA, MHRA Launch Liaison Program for Regulatory Cooperation

FDA and the UK's Medicines and Healthcare products Regulatory Agency announce a new liaison program designed to strengthen collaboration between the t...

latest-news-card-1
Human Drugs

Jaypirca Combination Cuts Progression Risk by 45% in CLL Trial: Lilly

Eli Lilly reports positive Phase 3 results for its BTK inhibitor Jaypirca (pirtobrutinib) in combination with venetoclax and rituximab.

latest-news-card-1
Human Drugs

Plausible Mechanism Faces Challenges: Commentary

Significant operational hurdles remain before FDA's Plausible Mechanism Framework can be broadly implemented, according to a commentary published by S...